Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-10-29
2000-04-18
Davenport, Avis M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 530324, A61K 3800, A61K 3828, C07K 500, C07K 700
Patent
active
060515511
ABSTRACT:
The invention relates to a method of administering a fatty acid-acylated insulin or insulin analog by inhalation, a method for treating diabetes by administering a fatty acid-acylated insulin or insulin analog by inhalation, and a method for treating hyperglycemia by administering a fatty acid-acylated insulin or insulin analog by inhalation.
REFERENCES:
patent: 5320094 (1994-06-01), Laube et al.
patent: 5364838 (1994-11-01), Rubsamen
patent: 5655523 (1997-08-01), Hodson et al.
patent: 5672581 (1997-09-01), Rubsamen et al.
patent: 5693609 (1997-12-01), Baker et al.
patent: 5700904 (1997-12-01), Baker et al.
patent: 5743250 (1998-04-01), Gonda et al.
patent: 5869602 (1999-02-01), Jonassen et al.
patent: 5888477 (1999-03-01), Gonda et al.
patent: 5898028 (1999-04-01), Jensen et al.
patent: 5898067 (1999-04-01), Balschmidt et al.
Allenby, et al., "The Absorption of Insulin Across the Respiratory Tract of the Guinea-Pig (U)," The Aerosol Society, Fourth Annual Conference pp. 129-134 (1990).
Arnst, C., "Inhale, don't inject," Business Week, Feb. 9, 1998, pp. 74-75.
Byron, P. R. and Patton, J. S., "Drug Delivery via the Respiratory Tract", J. Aerosol Medicine 7:49-75 (1994).
Edwards et al., Science 276:1868-1871 (1997).
Elliott, R.B., et al., "Parenteral absorption of insulin from the lung in diabetic children," Aust. Paediatr. J. 23: 293-297 (1987).
Hashimoto et al., "Synthesis of Palmitoyl Derivatives of Insulin and Their Biological Activities," Pharmaceutical Research, 6(2):171-176 (1989).
Hashizume, et al., "Improvement of Large Intestinal Absorption of Insulin by Chemical Modification with Palmitic Acid in Rats," J. Pharm. Pharmacol., 44:555-559 (1992).
Kohler, D., "Aerosols for systemic treatment," Lung, Suppl. 677-684 (1994).
Kohler, D., "Aerosols for systemic treatment," Lung, Suppl.:677-684 (1990).
Komada, et al., "Interatracheal Delivery of Peptide and Protein Agents: Absorption from Solution and Dry Powder by Rat Lung," J. Pharm. Sci. 83(6):863-867 (1994).
Komada, et al., "Intratracheal Delivery of Peptide and Protein Agents: Absorption from Solution and Dry Powder by Rat Lung, " J. Pharm. Sci. 83:863-867 (1994).
Lauber, B.L. et al., "Deposition, clearance, and effects in the Lung," Journal Aeorsol Medicine 4:286 (1991).
Lauber, B.L. et al., "Preliminary Study of the Efficacy of insulin aerosl delivered by oral inhalation in diabetic patients," JAMA, 269:2106-2109 (1994).
Liu, et al., "Pulmonary Delivery of Free and Liposomal Insulin," Pharm. Res. 10(2) :228-232 (1993).
Niven, R., "Delivery of Biotherapeutics by Inhalation Aerosol", Crit. Rev. in Therapeutic Drug Carrier Systems 12:151-231 (1995).
Patton, et al., "Routes of Delivery: Case Studies (2) Pulomonary delivery of peptides and proteins" Adv. Drug Del. Rev., 8: 179-196 (1992).
Patton, J. S. and Platz, R. M., "Aerosol Insulin- A Brief Review", in Respiratory Drug Delivery IV, P. Byron, Ed., Interpharm Press (1994).
Sayani, et al. "Systemic Delivery of Peptides and Proteins," Mucosae Critical Reviews in Therapeutic Drug Carrier Systems 13 (1&2) :85-84 (1996).
Wail "Pulmonary Absorption of Peptides and Proteins," Drug Delivery 2:1-20 (1995).
Whittingham, J. L., et al. Biochemistry 36:2826-2831 (1997)
Wigley, F.M., et al., "Insulin across respiratory mucosae by aerosol delivery," Diabetes, 20:552-556 (1971).
Yoshida, H., et al., "Absorption of insulin delivered to rabbit trachea using aerosol dosage form," Journal Pharmaceutical Sciences 68:670-671 (1979).
Hughes Benjamin Lee
Wolff Ronald Keith
Davenport Avis M.
Eli Lilly and Company
Kelley James J.
LandOfFree
Method for administering acylated insulin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for administering acylated insulin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for administering acylated insulin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2336398